基于CT衍生细胞外容积的列线图预测可切除肝细胞癌患者肝切除术后肝衰竭
本研究纳入两家医院共202例可切除肝细胞癌患者,术前接受多期增强CT检查,其中本院121例为训练队列、另一医院81例为验证队列,基于CT衍生细胞外容积(ECV)、血清白蛋白和血清总胆红素构建列线图。CT衍生ECV与术后病理肝纤维化分期强相关(p < 0.001,r = 0.591),列线图预测肝切除术后肝衰竭的AUC在训练队列为0.828、验证队列为0.821,均高于ALBI评分(分别为0.708和0.630)。
要点
- CT衍生ECV与术后病理肝纤维化分期强相关(p < 0.001,r = 0.591)。
- 列线图结合CT衍生ECV、血清白蛋白和血清总胆红素,训练队列AUC 0.828、验证队列AUC 0.821。
- 列线图预测肝切除术后肝衰竭的AUC高于ALBI评分,训练队列0.828 vs. 0.708(p = 0.004),验证队列0.821 vs. 0.630(p < 0.001)。
核心结论
- 基于CT衍生ECV的列线图有助于可切除肝细胞癌患者肝切除术后肝衰竭的术前预测。
研究设计与样本
- 回顾性纳入两家医院共202例可切除肝细胞癌患者,术前均行多期增强CT检查。
- 本院121例为训练队列,另一医院81例为验证队列。
- CT衍生ECV采用非增强期和平衡期增强CT图像测量。
- 列线图基于肝切除术后肝衰竭的独立预测因素构建,预测性能用受试者工作特征(ROC)分析评估,校准用Hosmer-Lemeshow检验评估,AUC比较用Delong检验。
关键影像表现/征象
- CT衍生ECV与背景肝术后病理纤维化分期强相关(p < 0.001,r = 0.591)。
诊断标准与关键数值
- 列线图结合CT衍生ECV、血清白蛋白(Alb)和血清总胆红素(Tbil),预测肝切除术后肝衰竭的AUC在训练队列为0.828、验证队列为0.821。
- ALBI评分预测肝切除术后肝衰竭的AUC在训练队列为0.708、验证队列为0.630。
- 列线图AUC高于ALBI评分:训练队列0.828 vs. 0.708(p = 0.004),验证队列0.821 vs. 0.630(p < 0.001)。
- 列线图预测肝切除术后肝衰竭的拟合优度在训练队列p = 0.621、验证队列p = 0.697。
- CT衍生ECV是可切除肝细胞癌患者肝切除术后肝衰竭的独立预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to develop and validate a nomogram based on extracellular volume (ECV) derived from computed tomography (CT) for predicting post-hepatectomy liver failure (PHLF) in patients with resectable hepatocellular carcinoma (HCC).
METHODS: A total of 202 patients with resectable HCC from two hospitals were enrolled and underwent multiphasic contrast-enhanced CT before surgery. One hundred twenty-one patients from our hospital and 81 patients from another hospital were assigned to the training cohort and the validation cohort, respectively. CT-derived ECV was measured using nonenhanced and equilibrium-phase-enhanced CT images. The nomogram was developed with independent predictors of PHLF. Predictive performance and calibration were assessed by receiver operator characteristic (ROC) analysis and Hosmer-Lemeshow test, respectively. The Delong test was used to compare the areas under the curve (AUCs).
RESULTS: CT-derived ECV had a strong correlation with the postoperative pathological fibrosis stage of the background liver (p < 0.001, r = 0.591). The nomogram combining CT-derived ECV, serum albumin (Alb), and serum total bilirubin (Tbil) obtained higher AUCs than the albumin-bilirubin (ALBI) score for predicting PHLF in both the training cohort (0.828 vs. 0.708; p = 0.004) and the validation cohort (0.821 vs. 0.630; p < 0.001). The nomogram showed satisfactory goodness of fit for PHLF prediction in the training and validation cohorts (p = 0.621 and 0.697, respectively).
CONCLUSIONS: The nomogram contributes to the preoperative prediction of PHLF in patients with resectable HCC.
KEY POINTS: • CT-derived ECV had a strong correlation with the postoperative pathological fibrosis stage of the background liver. • CT-derived ECV was an independent predictor of PHLF in patients with resectable HCC. • The nomogram based on CT-derived ECV showed a superior prediction efficacy than that of clinical models (including Child-Pugh stage, MELD score, and ALBI score).
引用
- Peng, Shen, Tang, et al. Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma. Eur Radiol. 2022. PMID: 35678856. doi:10.1007/s00330-022-08917-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。